对于Cryptosporidium特定的IMP脱酶抑制剂选择性的结构基础
Iain S Macpherson1, Sivapriya Kirubakaran, Suresh Kumar Gorla
1Departments of Biology, Brandeis University, MS009, 415 South Street, Waltham, Massachusetts 02454, USA.
Journal of the American Chemical Society
|January 8, 2010
概括
对于Cryptosporidium parvum感染,目前还没有有效的治疗方法. 研究人员确定了寄生虫的IMPDH酶的晶体结构,从而使潜在的药物疗法的高度选择性抑制剂的开发成为可能.
科学领域:
- 寄生虫学的寄生虫学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- Cryptosporidium parvum是一种重要的病原体,引起腹和营养不良,特别是在艾滋病患者中.
- 它也被认为是一个潜在的生物战剂,目前没有疫苗或有效的药物治疗方法.
- 这种寄生虫的生存取决于因氨酸5'-单酸脱酶 (IMPDH) 对于氨酸核酸合成.
研究的目的:
- 为了确定Cryptosporidium parvum IMPDH (CpIMPDH) 的晶体结构.
- 了解针对CpIMPDH的抑制剂选择性的结构基础.
- 引导开发针对Cryptosporidium感染的新型治疗剂.
主要方法:
- 使用X射线晶体学来确定CpIMPDH的三维结构.
- 基于结构的药物设计原则用于抑制剂优化.
- 进行了酶抑制试验,以评估抑制剂的强度和选择性.
主要成果:
- 成功获得了CPIMPDH的第一个晶体结构.
- 这些结构阐明了抑制剂选择性的基础分子机制.
- 新型低纳米抑制剂被合成,对CPIMPDH的选择性超过人类IMPDH的1000倍.
结论:
- 确定的CPIMPDH结构为合理的药物设计提供了基础.
- 已经开发出针对CpIMPDH的高度选择性抑制剂.
- 这些发现代表了有效治疗Cryptosporidium感染的重大进展.
更多相关视频
10:40Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
12:11A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.
Published on: July 9, 2012
相关概念视频
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
